Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
Provision of an NHS National Branded Interim - 1 June 2026
01/06/2026 - 30/04/2028 23 Months with an option or options to extend at the discretion of the authority up to a maximum of 25 months
Framework contract: £529,090,780 total value shared among 51 suppliers. Estimated equal shares shown below.
| Supplier | Identifier | Est. Share | Lots Won | Cross-References |
|---|---|---|---|---|
| ACCORD-UK LTD | 00079585 | ~£10,374,329 | 1 lot Lot 1 | - |
| ASCEND LABORATORIES (UK) LIMITED | 09164483 | ~£10,374,329 | 1 lot Lot 1 | - |
| ASPIRE PHARMA LIMITED | 06828501 | ~£10,374,329 | 1 lot Lot 1 | - |
| ASTRAZENECA UK LIMITED | 03674842 | ~£10,374,329 | 1 lot Lot 1 | LOBBYIST FTI Consulting LLP (6 quarters) Incisive Health Ltd (6 quarters) Teneo Strategy Limited (3 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (1 quarter) |
| AVENTIS PHARMA LIMITED | 01535640 | ~£10,374,329 | 1 lot Lot 1 | DONOR£101K across 3 donations To: Pauline Latham MP, Derek Thomas, Labour Party |
| CAMURUS AB | Procurement ID: PXNY-7785-WXRQ | ~£10,374,329 | 1 lot Lot 1 | - |
| CIPLA (EU) LIMITED | 04513292 | ~£10,374,329 | 1 lot Lot 1 | - |
| CONSILIENT HEALTH (UK) LIMITED | 05427634 | ~£10,374,329 | 1 lot Lot 1 | - |
| CST PHARMA LIMITED | 04212740 | ~£10,374,329 | 1 lot Lot 1 | - |
| DAY LEWIS MEDICAL LIMITED | 01904504 | ~£10,374,329 | 1 lot Lot 1 | - |
| ESSENTIAL PHARMA LIMITED | 07514667 | ~£10,374,329 | 1 lot Lot 1 | - |
| ESTEVE PHARMACEUTICALS LTD | 03393686 | ~£10,374,329 | 1 lot Lot 1 | - |
| EUMEDICA PHARMA LTD | 12585612 | ~£10,374,329 | 1 lot Lot 1 | - |
| FLEXIPHARM AUSTRADING LIMITED | 11368401 | ~£10,374,329 | 1 lot Lot 1 | - |
| FLYNN PHARMA LIMITED | FC018156 | ~£10,374,329 | 1 lot Lot 1 | - |
| GLENMARK PHARMACEUTICALS EUROPE LIMITED | 05040260 | ~£10,374,329 | 1 lot Lot 1 | - |
| GRUNENTHAL LIMITED | 03658396 | ~£10,374,329 | 1 lot Lot 1 | - |
| JANSSEN-CILAG LIMITED | 01027904 | ~£10,374,329 | 1 lot Lot 1 | LOBBYIST Ovid Consulting Ltd (4 quarters) |
| LOGIXX PHARMA LIMITED | 07209211 | ~£10,374,329 | 1 lot Lot 1 | - |
| LUPIN HEALTHCARE (UK) LIMITED | 06925119 | ~£10,374,329 | 1 lot Lot 1 | - |
| MARTINDALE PHARMA (MACARTHYS LABORATORIES LIMITED) | Procurement ID: PMCW-3552-YDNX | ~£10,374,329 | 1 lot Lot 1 | - |
| MEDAC PHARMA LLP | OC415849 | ~£10,374,329 | 1 lot Lot 1 | - |
| MERCK SHARP & DOHME (UK) LIMITED | 00233687 | ~£10,374,329 | 1 lot Lot 1 | - |
| MERCURY PHARMACEUTICALS LIMITED | 02619880 | ~£10,374,329 | 1 lot Lot 1 | - |
| MORNINGSIDE PHARMACEUTICALS LIMITED | 02672877 | ~£10,374,329 | 1 lot Lot 1 | - |
| MSN LABORATORIES EUROPE LIMITED | 10185013 | ~£10,374,329 | 1 lot Lot 1 | - |
| NAPP PHARMACEUTICALS LIMITED | 03690299 | ~£10,374,329 | 1 lot Lot 1 | - |
| NEURAXPHARM UK LIMITED | 10918621 | ~£10,374,329 | 1 lot Lot 1 | - |
| NORDIC PHARMA LIMITED | 01489084 | ~£10,374,329 | 1 lot Lot 1 | - |
| NORGINE PHARMACEUTICALS LIMITED | 03527131 | ~£10,374,329 | 1 lot Lot 1 | - |
| NOVARTIS PHARMACEUTICALS UK LIMITED | 00119006 | ~£10,374,329 | 1 lot Lot 1 | DONOR£3K across 2 donations To: Mr Nicholas Palmer LOBBYIST M&F Health (7 quarters) Sovereign Strategy Limited (1 quarter) MP LINK Mr David Lammy— Employment and earnings |
| ORPHALAN UK LTD | 11663393 | ~£10,374,329 | 1 lot Lot 1 | - |
| PFIZER LIMITED | 00526209 | ~£10,374,329 | 1 lot Lot 1 | DONOR£41K across 4 donations To: Progressive Britain Ltd (formally Progress Ltd) LOBBYIST Portland PR Limited (20 quarters) Ovid Consulting Ltd (3 quarters) Hanover Communications International Limited (3 quarters) MHP Communications (1 quarter) Incisive Health Ltd (1 quarter) FORMER MP John Austin— Gifts, benefits and hospitality from UK sources (former) |
| RENASCIENCE PHARMA LIMITED | 09420886 | ~£10,374,329 | 1 lot Lot 1 | - |
| ROSEMONT PHARMACEUTICALS LIMITED | 00924648 | ~£10,374,329 | 1 lot Lot 1 | - |
| SANTEN UK LIMITED | 09194443 | ~£10,374,329 | 1 lot Lot 1 | - |
| SELECTIVE SUPPLIES LIMITED | 03794482 | ~£10,374,329 | 1 lot Lot 1 | - |
| SERB LTD | 08274910 | ~£10,374,329 | 1 lot Lot 1 | - |
| STIRLING ANGLIAN PHARMACEUTICALS LIMITED | SC453258 | ~£10,374,329 | 1 lot Lot 1 | - |
| SUN PHARMA UK LIMITED | 02992795 | ~£10,374,329 | 1 lot Lot 1 | - |
| SWEDISH ORPHAN BIOVITRUM LTD | 04369760 | ~£10,374,329 | 1 lot Lot 1 | - |
| SYNCHRONY (CNX THERAPEUTICS LIMITED) | Procurement ID: PPHG-3941-MWHZ | ~£10,374,329 | 1 lot Lot 1 | - |
| SYRI LIMITED | 07457011 | ~£10,374,329 | 1 lot Lot 1 | - |
| TAKEDA UK LIMITED | 03362860 | ~£10,374,329 | 1 lot Lot 1 | LOBBYIST Hill & Knowlton Limited (3 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (2 quarters) Burkitt Communications Ltd (1 quarter) Incisive Health Ltd (1 quarter) FORMER MP Sir Kevin Barron— Employment and earnings (former) |
| TEVA UK LIMITED | 00302461 | ~£10,374,329 | 1 lot Lot 1 | - |
| THEA PHARMACEUTICALS LIMITED | 06505496 | ~£10,374,329 | 1 lot Lot 1 | - |
| THORNTON & ROSS LIMITED | 00185947 | ~£10,374,329 | 1 lot Lot 1 | - |
| UNICORN PHARMACEUTICALS LIMITED | 14867894 | ~£10,374,329 | 1 lot Lot 1 | - |
| VIATRIS UK HEALTHCARE LIMITED (MYLAN) | Procurement ID: PQLZ-4934-WXRZ | ~£10,374,329 | 1 lot Lot 1 | - |
| ZENTIVA PHARMA UK LIMITED | 02158996 | ~£10,374,329 | 1 lot Lot 1 | - |
| ZYDUS PHARMACEUTICALS UK LTD | 14646636 | ~£10,374,329 | 1 lot Lot 1 | - |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 1 lots, each awarded separately. 53 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Jun 2026 – Apr 2028 | £1,346,663,020 £529,090,780 initial term | 53 | ACCORD-UK LTD ASCEND LABORATORIES (UK) LIMITED ASPIRE PHARMA LIMITED ASTRAZENECA UK LIMITED AVENTIS PHARMA LIMITED CAMURUS AB CIPLA (EU) LIMITED CONSILIENT HEALTH (UK) LIMITED CST PHARMA LIMITED DAY LEWIS MEDICAL LIMITED ESSENTIAL PHARMA LIMITED ESTEVE PHARMACEUTICALS LTD EUMEDICA PHARMA LTD FLEXIPHARM AUSTRADING LIMITED FLYNN PHARMA LIMITED GLENMARK PHARMACEUTICALS EUROPE LIMITED GRUNENTHAL LIMITED JANSSEN-CILAG LIMITED LOGIXX PHARMA LIMITED LUPIN HEALTHCARE (UK) LIMITED MARTINDALE PHARMA (MACARTHYS LABORATORIES LIMITED) MEDAC PHARMA LLP MERCK SHARP & DOHME (UK) LIMITED MERCURY PHARMACEUTICALS LIMITED MORNINGSIDE PHARMACEUTICALS LIMITED MSN LABORATORIES EUROPE LIMITED NAPP PHARMACEUTICALS LIMITED NEURAXPHARM UK LIMITED NORDIC PHARMA LIMITED NORGINE PHARMACEUTICALS LIMITED NOVARTIS PHARMACEUTICALS UK LIMITED ORPHALAN UK LTD PFIZER LIMITED RENASCIENCE PHARMA LIMITED ROSEMONT PHARMACEUTICALS LIMITED SANTEN UK LIMITED SELECTIVE SUPPLIES LIMITED SERB LTD SWEDISH ORPHAN BIOVITRUM LTD STIRLING ANGLIAN PHARMACEUTICALS LIMITED VIATRIS UK HEALTHCARE LIMITED (MYLAN) SUN PHARMA UK LIMITED SYNCHRONY (CNX THERAPEUTICS LIMITED) SYRI LIMITED TAKEDA UK LIMITED TEVA UK LIMITED THEA PHARMACEUTICALS LIMITED THORNTON & ROSS LIMITED UNICORN PHARMACEUTICALS LIMITED ZENTIVA PHARMA UK LIMITED ZYDUS PHARMACEUTICALS UK LTD | active |
Notices published under the Procurement Act 2023 name every bidder, including unsuccessful ones.
| Bidder | Bid on | Outcome |
|---|---|---|
| ACCORD-UK LTD | Lot 1 | Won |
| ASCEND LABORATORIES (UK) LIMITED | Lot 1 | Won |
| ASPIRE PHARMA LIMITED | Lot 1 | Won |
| ASTRAZENECA UK LIMITED | Lot 1 | Won |
| AVENTIS PHARMA LIMITED | Lot 1 | Won |
| CAMURUS AB | Lot 1 | Won |
| CIPLA (EU) LIMITED | Lot 1 | Won |
| CONSILIENT HEALTH (UK) LIMITED | Lot 1 | Won |
| CST PHARMA LIMITED | Lot 1 | Won |
| DAY LEWIS MEDICAL LIMITED | Lot 1 | Won |
| ESSENTIAL PHARMA LIMITED | Lot 1 | Won |
| ESTEVE PHARMACEUTICALS LTD | Lot 1 | Won |
| EUMEDICA PHARMA LTD | Lot 1 | Won |
| FLEXIPHARM AUSTRADING LIMITED | Lot 1 | Won |
| FLYNN PHARMA LIMITED | Lot 1 | Won |
| GLENMARK PHARMACEUTICALS EUROPE LIMITED | Lot 1 | Won |
| GRUNENTHAL LIMITED | Lot 1 | Won |
| JANSSEN-CILAG LIMITED | Lot 1 | Won |
| LOGIXX PHARMA LIMITED | Lot 1 | Won |
| LUPIN HEALTHCARE (UK) LIMITED | Lot 1 | Won |
| MARTINDALE PHARMA (MACARTHYS LABORATORIES LIMITED) | Lot 1 | Won |
| MEDAC PHARMA LLP | Lot 1 | Won |
| MERCK SHARP & DOHME (UK) LIMITED | Lot 1 | Won |
| MERCURY PHARMACEUTICALS LIMITED | Lot 1 | Won |
| MORNINGSIDE PHARMACEUTICALS LIMITED | Lot 1 | Won |
| MSN LABORATORIES EUROPE LIMITED | Lot 1 | Won |
| NAPP PHARMACEUTICALS LIMITED | Lot 1 | Won |
| NEURAXPHARM UK LIMITED | Lot 1 | Won |
| NORDIC PHARMA LIMITED | Lot 1 | Won |
| NORGINE PHARMACEUTICALS LIMITED | Lot 1 | Won |
| NOVARTIS PHARMACEUTICALS UK LIMITED | Lot 1 | Won |
| ORPHALAN UK LTD | Lot 1 | Won |
| PFIZER LIMITED | Lot 1 | Won |
| RENASCIENCE PHARMA LIMITED | Lot 1 | Won |
| ROSEMONT PHARMACEUTICALS LIMITED | Lot 1 | Won |
| SANTEN UK LIMITED | Lot 1 | Won |
| SELECTIVE SUPPLIES LIMITED | Lot 1 | Won |
| SERB LTD | Lot 1 | Won |
| STIRLING ANGLIAN PHARMACEUTICALS LIMITED | Lot 1 | Won |
| SUN PHARMA UK LIMITED | Lot 1 | Won |
| SWEDISH ORPHAN BIOVITRUM LTD | Lot 1 | Won |
| SYNCHRONY (CNX THERAPEUTICS LIMITED) | Lot 1 | Won |
| SYRI LIMITED | Lot 1 | Won |
| TAKEDA UK LIMITED | Lot 1 | Won |
| TEVA UK LIMITED | Lot 1 | Won |
| THEA PHARMACEUTICALS LIMITED | Lot 1 | Won |
| THORNTON & ROSS LIMITED | Lot 1 | Won |
| UNICORN PHARMACEUTICALS LIMITED | Lot 1 | Won |
| VIATRIS UK HEALTHCARE LIMITED (MYLAN) | Lot 1 | Won |
| ZENTIVA PHARMA UK LIMITED | Lot 1 | Won |
| ZYDUS PHARMACEUTICALS UK LTD | Lot 1 | Won |
| Luye Pharma Ltd | Lot 1 | Unsuccessful |
| UNI HEALTH DISTRIBUTION LTD | Lot 1 | Unsuccessful |
Weightings from the notice.
Government spending data: These suppliers have received £1,001,899,009 in 3,480 payments (over £25k) from Department of Health and Social Care, UK Health Security Agency, Manchester University NHS Foundation Trust, NHS England, Guy's and St Thomas' NHS FT and 20 more public bodies (2010-04-19 to 2026-03-31).
Changes the buyer published to this notice after it first appeared.
Update to Procurement Ref
Change to Extension Options